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Epilepsy care has been identified as a major global issue – and there are many recognised 
concerns in the UK for children and young people with the condition.  A proposed new model 
could help to increase multi-sector integration, facilitate better outcomes, and offer lessons 
for improving care of other long-term conditions.  
 
The General Assembly of the World Health Organisation passed a resolution on the global burden of 
epilepsy last year highlighting the need for ‘coordinated action at the country level to address its 
health, social and public knowledge implications’. This represented a welcome landmark in the 
global struggle to improve epilepsy treatment and reduce the associated stigma1. The resolution 
highlighted the challenges faced by health services in providing care for the 50 million people 
affected by epilepsy across the world. Due to shortages of medicines and appropriately trained 
doctors, fewer than 25% of individuals with epilepsy in low-income countries receive adequate 
treatment, which can completely control symptoms in up to 70% of cases.   Further, widespread 
stigmatisation and discrimination mean that individuals in low, middle and high-income countries 
continue to face difficulties in education, employment, relationships and reproduction.  
 
Global progress and challenges in epilepsy care 
The approval of this resolution, however, also offers an opportunity to celebrate advances that have 
been made in recent years, with improvements in care as a result of new diagnostic techniques2 and 
anti-epileptic drugs, and a growing role for other treatments such as epilepsy surgery3 and the 
ketogenic diet4.  There has also been progress towards addressing the stigma associated with 
epilepsy. In 1997, the WHO and partners launched the Global Campaign against Epilepsy (GCAE): 
‘Out of the Shadows5’, with the aim of improving ‘acceptability, treatment, services and prevention 
of epilepsy worldwide’. A major focus of the campaign was addressing ‘myths and superstitions,’ and 
promoting public and professional understanding of epilepsy, as a universal, treatable brain 
disorder. They highlighted that a lack of understanding of epilepsy operates at all levels - including 
patients, health care professionals and policy makers - contributing to an under-estimation of the 
disease burden associated with epilepsy with under-treatment of patients.   
Following the launch of the GCAE, several countries piloted projects to address stigma, understand 
the disease burden, and deliver effective epilepsy care at scale.  For example, one project in China6 
screened over 55,000 people and reported lifetime epilepsy prevalence of around 7/1000, almost 
double the previous best estimate.  Since then, recognition and treatment of epilepsy has received 
substantial attention and resources from national policy makers, providing a model of evidence-
based care, and improved quality of life for many patients at relatively little cost. 
Lastly, the model of partnership working between patient and professional groups, and recognition 
of the role that social and cultural factors can play in successful medical treatment, make epilepsy 
care an exciting model for tackling wider health challenges. The WHO has identified non-
communicable diseases (NCDs), such as epilepsy, as the major cause of deaths worldwide, and called 
for a paradigm shift in NCD strategies, involving empowerment of people and communities, a human 
rights and equity-based approach, and multi-sectoral action7 . Whether at local, national or 
international levels, epilepsy partnerships between patients/advocacy groups and health agencies 
have demonstrated the impact and cost-effectiveness of such strategies, offering lessons that can be 
applied across a wide range of conditions.   While the priorities and context of epilepsy care varies 
widely between countries, a closer look at developments in the care of childhood epilepsies in the 
UK over the last two decades reveals very similar achievements, ongoing challenges and wider 
lessons for healthcare delivery. 
 
Key milestones in improving paediatric epilepsy care in the United Kingdom 
Epilepsy is one of the major long-term conditions (LTCs) affecting CYP, and is the most common 
neurological disorder in this age group.  More than 1 in 200 children and young people under the 
age of 25 have epilepsy, with the total in the UK estimated at over 112,0008.  However, the identified 
issues with epilepsy care do not only involve those with confirmed epilepsy, but also the process of 
diagnosis itself, with rates of incorrect diagnosis of epilepsy having been historically high.  One 
study9 in 2006 found that up to 40% of CYP referred to specialist clinics eventually transpired not to 
have the condition.  The corollary of this startling statistic is many of this group had been diagnosed 
and consequently inappropriately commenced on antiepileptic drug treatment.  Yet, at the other 
end of the spectrum, there are a significant number of children who are not being adequately 
treated, with estimates that up to 70% of people with epilepsy could be free of seizures if 
appropriately managed8.   
The reasons behind sub-optimal outcomes for children and young people are perhaps best 
understood by considering some of the seminal initiatives in epilepsy care over recent years.  In the 
early 2000s, a well-publicised enquiry into practice at one hospital highlighted many of the intrinsic 
challenges of accurately diagnosing epilepsy in children, with over-diagnosis and the overprescribing 
of antiepileptic drugs10. Rather than problems with individual clinical assessment, however, the 
enquiry instead pinpointed systemic failings.  This view was reinforced more widely in the National 
Sentinel Clinical Audit of Epilepsy-Related Deaths11, which uncovered specific shortcomings in 
access, quality of care and communication.  In particular, therapeutic management was found to 
have been inadequate in almost 50%, and 59% of deaths were felt could possibly have been avoided. 
In response to such findings, the British Paediatric Neurology Association (BPNA) has led a 
comprehensive, long-term programme to improve outcomes through transforming the quality of 
epilepsy services. This started with the recognition of the fact that poor communication and a 
variation in access to investigations existed, and that resources were not being appropriately 
utilised12. In 2003, the organisation published a report setting out an integrated model across 
primary, secondary, tertiary and quaternary healthcare.  The report recommended improved access 
to specialists and appropriate investigations, better selection of eligible patients for surgical 
intervention, improved support for clinical networks, and a need for earlier social care and education 
involvement as the way towards improving care. It also emphasised the essential role of the epilepsy 
nurse specialists and proposed the creation of a new position - the paediatrician with ‘an expertise in 
epilepsy’.  These roles were reinforced by the launch of the Paediatric Epilepsy Training (PET) 
courses (www.BPNA.org.uk/PET), which became the gold standard for training in epilepsy; to date in 
excess of 5000 doctors and nurses have moved through these courses nationally13.  
Another important step came with the introduction of national guidelines for childhood epilepsy 
care;1415 , as well as providing recommendations regarding clinical practice, these have also outlined 
the model of what a ‘good’ epilepsy service should look like.  The guidelines also acknowledged the 
wider effects of an epilepsy diagnosis, and made mention of a whole system approach. 
Unfortunately, making specific recommendations about mental health, education, social care and 
the third sector was beyond the scope of the guidelines at the time, and so a broader unified, 
national strategy did not form part of this none-the-less practical guidance.  NICE went further still in 
2013, publishing a valuable Quality Standard which described high priority areas16.  Once again, 
however, whilst an integrated approach was recommended in the accompanying document, it was 
not reflected in the nine specific standards as the design methodology required them to be directly 
derived from the NICE recommendations. 
 
Evidence of the need to improve epilepsy care in the United Kingdom 
Mirroring the global picture described above, more recent data on the care of CYP with epilepsy in 
the UK continue to demonstrate significant ongoing concerns, albeit alongside some areas of major 
progress. For example, a 2013 report examining avoidable mortality and morbidity in childhood 
epilepsy17 found that 24% of studied deaths were potentially avoidable. Despite improvement in 
some areas, there was ongoing evidence of inadequate communication, service fragmentation and 
problems with assessment and classification. This report emphasised the importance of adhering to 
the now-established national guidelines, and also recommended a named paediatrician with 
appropriate expertise as a means to improve the coordination of care, the need for clear care plans, 
and involving families in management. 
Concerns about the quality of epilepsy care have been backed up by findings in Epilepsy12.  The first 
round of this national audit highlighted the presence of longstanding issues including misdiagnosis, 
poor communication and a variation in care18.  Though the second round, published in 2014, found 
some improvement in its measured indicators, these same problems were continuing19 (Figure 1).  
By way of example, the proportion of paediatric services with an epilepsy specialist nurse has 
increased from 46% to 59%. Some argue that this is good progress, but it remains the case that over 
one-third of paediatric services across the country do not contain a vital component of an adequate 
service.   
It is clear therefore that, despite considerable action over a period of many years, the desired 
improvement has not been equitably seen across the UK.  The difficulties encountered by many CYP 
are reflected in the experiences, of one of the authors of this article, MP, whose history is 
summarised in our case study (Figure 3).  There remains a set of diverse barriers that need to be 
overcome, all of which require urgent attention in order to make further improvements.  Two key  
factors would appear to be the persisting fragmentation of services, and limited success in 
developing genuine partnership working with children, young people and families.   
 
Focus on integration  
Epilepsy has a broad functional impact on CYP, at a vital point in their development - something 
which is being increasingly recognised, with growing evidence that even children with ‘well-
controlled’ seizures can experience problems with learning and behaviour20,21.  Any child with 
epilepsy may require input from a combination of agencies, including physical health, mental health, 
social care and education.  Although fragmentation of these services has been acknowledged, few 
practical moves towards achieving integration have been initiated.  This is surprising, given that such 
a model would be well suited to meeting the needs of CYP with epilepsy, bringing improved 
coordination of care and a whole-system approach22.  However, recent UK policy developments, 
listed in Table 123-24, promote many of the necessary conditions for integration to occur: leadership, 
a collaborative culture, financial incentives and accountability25.  It is essential that an integrated 
approach is adopted in order to make further necessary improvements, and now appears to be the 
right time. 
 
A model for integrated epilepsy care for children and young people 
Importantly, CYP, parents and professionals have confirmed a shared appetite for integrated 
epilepsy care.  A novel collaborative group (comprising a prominent academic institution, an 
Academic Health Science Network, a healthcare Trust working in both community and hospital 
settings, and – uniquely - a leading third sector organisation) has been working to address epilepsy 
care for CYP.  Their recent qualitative work26 has combined existing evidence with the perspectives 
of these key groups, through focus groups, interviews and questionnaires, aiming to pinpoint 
barriers and enablers to improving outcomes.  Thematic analysis uncovered four clearly identifiable 
enablers that would, taken together, enhance care: improving communication, better data, tailored 
care to meet individual needs, and a whole systems strategy.   
This work highlighted the fragmentation of services that continues to perpetuate inadequate care, 
adding that use of these identified enablers would facilitate closure of the gap between current 
services and desired standards.  The report went on to recommend specific innovative tools which, 
taken together, would act as a model towards achieving a truly integrated system (Figure 2).  A key 
element of this is a national epilepsy registry which, when used alongside individualised care plans, 
would allow the use of up-to-date data to directly inform changes and adjustments in an individual’s 
care.  This would facilitate tailored care, reflecting that ‘epilepsy’ is an umbrella term for a 
heterogenous group of conditions (i.e. ‘the epilepsies’) and also the unique ways in which the 
condition impacts on each CYP and their family.  A registry would also allow group data to be more 
easily and frequently collated than at present, enabling services to regularly audit relevant 
indicators, and commissioners to shape provision according to the true needs of their population, to 
the ultimate benefit of individual service users.   
The co-creation of young people’s networks, currently being piloted, will ensure young people and 
families are rightly placed at the centre of their care, having a true influence both on their own care 
and on wider service provision.  This sits alongside recent national work to enhance existing regional 
epilepsy professional networks, such that best practice is shared and innovation spread.  It is 
anticipated that this foundation of optimised communication will lead to the co-production of other 
formal tools to enhance communication, such as a shared electronic record.  Lastly, the model 
recognises the overall need for a wider systems strategy, encompassing all relevant sectors to the 
care of CYP with epilepsy.  Therefore an economic analysis that specifically determines the financial 
benefits and cost-effectiveness of a multi-sector approach has been commissioned, helping to 
support implementation of all of the tools, and in time leading to a ‘year of care’ tariff that properly 
represents the broad range of services involved.  
Overall, this model acknowledges that every child or young person with epilepsy is different, with a 
unique combination of needs requiring input from different agencies.  This proposed move to a 
person-centred, individualised approach would see services ‘wrap-around’ each CYP, with 
development of tailored plans encompassing all relevant agencies, and the success or failure being 
determined by meaningful outcomes.  This requires a paradigm shift in epilepsy care with, for 
example, seizure freedom seen not as the end goal, but rather as one important outcome alongside 
others such as improved school attendance, educational attainment and gainful employment.  
Importantly, the model also recognises the overwhelming need to give CYP and families greater 
control over their condition.       
It is clear to see how applying the model to our case study (Figure 3) could have addressed the four 
interlinked themes identified above and have improved her experience in several ways. First, 
improving communication between her, her family, and the medical and school teams working with 
her could have ensured that all relevant parties were aware of the support and care she needed 
from school, for example making them aware of how her seizures typically manifest, and setting out 
clear instructions for how staff should appropriately respond. This could have reduced the 
consequences of her epilepsy on school attendance and educational attainment, as well as 
minimised the emotional and social impact of epilepsy on her life. Second, an individualised care 
plan could have facilitated this cross-sectoral communication and helped establish shared goals and 
priorities between her, her family and all relevant professionals.  Third, a whole-systems strategy 
could have reduced geographical variation in epilepsy services and ensured that appropriate 
structures were in place to support cross-sectoral working and participation of young people in 
improving epilepsy services. For example, young people’s networks have been shown to be an 
effective tool to involve young people in shaping their care, contributing to improved outcomes27.  
Similar benefits could be anticipated for CYP with epilepsy, however there is wide variation in the 
availability of such opportunities between different areas.   No such young people’s network was 
available when MP could have benefitted from this support;  indeed, she did not have any access to 
an epilepsy specialist nurse (who would often help coordinate such groups) through her time at 
secondary school. Lastly, taking part in an epilepsy registry could have ensured that more 
information on the educational, psychological and social impact of epilepsy was available to the 
professionals caring for MP. In addition, the registry could play a key role in investigating how 
health, educational, occupational and social outcomes can be improved for children and young 
people with epilepsy in the future.  
 
Lessons for other long-term conditions 
Whilst epilepsy, with its demonstrated effect on a young person's learning and behaviour, lends 
itself particularly well to a multi-sector integrated approach, there is also a clear role for better 
partnership-working in the other common LTCs of childhood.  For example, there is evidence that 
poorly-controlled asthma or diabetes leads to lower school or college attendance, and these 
conditions therefore also have an educational and socio-economic impact. While the specific context 
will differ between conditions, the enablers of improved communication, better data, a tailored 
(individual) approach, and a unified national strategy offer a useful template for co-ordinated action 
to improve care of other long-term conditions. Equally, the concepts of person-centred care, and 
including the voice of CYP - key elements in our integrated model for epilepsy - are increasingly 
prioritised in wider health and care circles28.  We therefore anticipate the integrated model for 
epilepsy care will prove similarly invaluable in promoting optimal care for CYP in other LTCs. 
 
Conclusion 
Both global and UK strategies to support people with epilepsy have succeeded in making important 
achievements. However, as acknowledged recently by the WHO, epilepsy care worldwide continues 
to face challenges.  In the UK, significant concerns remain about the quality and variation of care 
that is provided, with multiple sources over many years demonstrating persisting systemic failures. 
Our proposed model of integrated epilepsy care offers the opportunity to deliver more effective, 
person-centred, and efficient care through effective partnership working between CYP, families and 
professionals across health, educational, social care and voluntary sectors.  We believe this approach 
may offer useful lessons for policy and practice development in other countries and different 
specialities, in particular for strategies to address the growing global burden of NCDs through patient 
empowerment and co-ordinated action across sectors.  
  
Key messages: 
 Despite a number of important improvements in diagnostic and treatment 
techniques in recent years, epilepsy care for children and young people remains a 
concern in the UK, as well as globally.  
 In order to improve outcomes, a system-wide approach is needed that reflects the 
broad functional impact of epilepsy. 
 There is a need to reduce fragmentation in epilepsy services for CYP, 
encompassing all sectors involved and working in partnership with CYP and 
families. 
 A model towards achieving true integration has recently been developed, utilising 
tools that enable improved communication, better data, tailored care and a 
whole-system strategy. This offers a pathway for improving epilepsy care in other 
settings, and also for other long-term conditions. 
Tables and figures 
Figure 1: % Clinical Performance indicator results for Round 1 (2012) and Round 2 (2014), 
Epilepsy1219.  ‘Whiskers’ indicate 95% confidence intervals. 
 
 
 
 
 
 
 
Table 1: Levers for an integrated system for epilepsy care in CYP 
 
  Legislation: The Children and Families Act 2014 delivered a legal requirement 
for education, social care and healthcare to work together and commission 
jointly. 23 
Political will: There were specific calls from cross-party MPs for greater 
integration in epilepsy care following the passing of the Children and Families 
Act 2014.  This has been recently reinforced in a Backbench Debate on 
epilepsy. 24 
Health policy: The NHS Outcomes Framework includes a goal to improve the 
quality of life for people with long-term conditions, alongside a specific aim to 
reduce unplanned hospital admissions for young people with epilepsy. 25 
  Figure 2: Model for integrated epilepsy care for CYP26  
 
 
  
Figure 3: Case study 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
I had my first tonic-clinic seizure at 11 months, losing all use of my right side, and was 
diagnosed with tuberous sclerosis complex.  Throughout my childhood my tonic-clinic 
seizures were well-controlled with medication, but I continued to have absence seizures. 
 
Communication has always been an issue. At school, most teachers thought “seizures are 
just when people drop to the floor though aren't they?” If they had understood my seizures 
better then I wouldn't have missed so much school (60 days in 5 years), as I was needlessly 
sent home after each absence.  I knew my condition best, and could judge if I was okay to 
stay at school, but instead my mother regularly had to leave work and pick me up. Equally, 
one of my seizure triggers is stress, and I would have more absences around exam periods.  
I was made to sit exams without any extra support, which I know would have helped me to 
do better if it was in place.  Conversely, my doctors rarely asked about how my epilepsy 
affected me in day-to-day life.  A better appreciation of this would have helped me get the 
care I needed at various points.  What I needed most was a way for those caring for me to 
address the things that concerned me.   
 
This was also true during transition, and with my adult neurologists.  I had a tonic-clonic 
seizure at work (13 years after the last) and an 'urgent' neurology appointment was 
promised.  I was really anxious and needed to speak with someone quickly, but did not get 
an appointment until 5 months later.  Recently, I wanted to see a genetic counsellor to 
discuss issues around having my own family, but was told ' you're only 21 and don't need 
that now'.  This isn’t true, it’s just frustrating. 
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